Proteomics International’s Managing Director, Dr Richard Lipscombe, featured on 6PR Afternoons on the 9th of October 2023 to discuss the alarming prevalence of DKD in the UK and the USA, and a call to action for Australia to take decisive steps now to prevent a similar fate. The Company’s test for DKD, PromarkerD is currently being rolled out in the USA and can predict the onset of the disease up to four years in advance.
You can listen to the 8-minute discussion here and how Proteomics International can help to solve this heath pandemic.